Wegener's granulomatosis in the head and neck region;Morbus Wegener im kopf-hals-bereich

HNO

Volumn 52, Issue 10, 2004, Pages 935-947

  Gottschlich, S ^a   Ambrosch, P ^a   Gross, W L ^b   Hellmich, B ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ANCA; Glomerulonephritis; Respiratory tract; Vasculitis; Wegener's granulomatosis

Indexed keywords

ANTIBIOTIC AGENT; AUTOANTIBODY; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; ETANERCEPT; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ARTHRALGIA; COMPUTER ASSISTED TOMOGRAPHY; CONJUNCTIVITIS; DIFFERENTIAL DIAGNOSIS; DYSPNEA; EPILEPSY; EPIPHORA; EPISCLERITIS; EXTERNAL OTITIS; GINGIVA HYPERPLASIA; GLOMERULONEPHRITIS; HEAD AND NECK DISEASE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNER EAR DISEASE; LABORATORY TEST; LARYNGOPLASTY; LASER SURGERY; MENINGITIS; MIDDLE EAR DISEASE; NOSE MALFORMATION; NOSE RECONSTRUCTION; PNEUMOCYSTIS PNEUMONIA; POLYNEUROPATHY; PRACTICE GUIDELINE; REVIEW; SINUSITIS; STRIDOR; SUBGLOTTIC STENOSIS; SYMPTOMATOLOGY; TRACHEA RECONSTRUCTION; TRACHEOTOMY; VASCULITIS; WEGENER GRANULOMATOSIS;

AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY PAPILLARY NECROSIS; LUNG DISEASES; MALE; MIDDLE AGED; NASAL MUCOSA; OTORHINOLARYNGOLOGIC DISEASES; PROGNOSIS; RECURRENCE; WEGENER GRANULOMATOSIS;

EID: 5444233515     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00106-004-1118-9     Document Type: Review

References (26)

1. Devaney K, Ferlito A, Hunter B, Devaney S, Rinaldo A (1998) Wegener's granulomatosis of the head and neck. Ann Otol Rhinol Laryngol 107: 439-445
2. Devaney K, Travis W, Hoffman G, Leavitt R, Lebovics R, Fauci A (1990) Interpretation of head and neck biopsies in Wegener's granulomatosis 14: 555-564
3. Eliachar I, Chan J, Akst L (2002) New approaches to the management of subglottic stenosis in Wegener's granulomatosis Cleve Clin J Med 69 (Suppl) SII149-151
4. Fauci A, Haynes B, Katz P, Wolff S (1983) Wegener's granulomatosis prospective clinical and therapeutic experience with 85 patients for 21 years Ann Intern Med 98: 76-85
5. Gross WL, Schmitt W, Csernok E (2001) ANCA and associated diseases Immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 1993 1-2
6. Gross WL, Schnabel A, Trabandt A (2000) New perspectives in pulmonary angiitis. From pulmonary angiitis and granulomatosis to ANCA associated vasculitis. Sarcoidosis Vase Diffuse Lung Dis 17: 33-52
7. Gubbels S, Barkhuizen A, Hwang P (2003) Head and neck manifestations of Wegener's granulomatosis Otolaryngol Clin N Am 36 685-705
8. Hellmich B, Ehren M, Lindstaedt M, Meyer M, Pfohl M, Schatz H (2001) Anti-MPO-ANCA-positive microscopic polyangiitis following subacute bacterial endocarditis Clin Rheumatol 20. 441-443
9. Hoffman GS (1998) Classification of the systemic vasculitides. Clin Exp Rheumatol 16: 111-115
10. Jennette J, Falk RJ, Andrassy K et al. (1994) Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192
11. Jennings C, Jones N, Dugar J, Powell R, Lowe J (2003) Wegener's granulomatosis - a review of diagnosis and treatment in 53 subjects Rhinology 36 188-191
12. Klinger H (1931) Grenzformen der Periarteriitis nodosa Frankf Zschr Pathol 42: 455-480
13. Lamprecht P, Voswinkel J, Lilienthal T, Noelle B, Heller M, Gross WL, Gause A (2002) Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis Rheumatology (Oxford) 41 1303-1307
14. Leavitt R, Fauci A, Bloch D et al. (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis Arthritis Rheum 33 1101-1107
15. Lebovics RS, Huffman GS, Leavitt RY et al (1992) The management of subglottic stenosis in patients with Wegener's granulomatosis Laryngoscope 102: 1341-1345
16. McDonald T, DeRemee R (1983) Wegener's granulomatosis Laryngoscope 93: 220-231
17. McDonald T, DeRemee R (1993) Head and neck involvement in Wegener's granulomatosis (WG). In: Gross WL (ed) ANCA-Associated Vasculitides: Immunological and Clinical Aspects. Plenum Press, New York, pp 309-313
18. Paulsen IJ, Rudert H (2001) Erscheinungsbild primarer Vasculitiden im HNO-Bereich Z Rheumatol 60 219-225
19. Pirsig W, Pentz S, Lenders H (1993) Repair of saddle nose deformity in Wegener's granulomatosis and ectodermal dysplasia. Rhinology 31: 69-72
20. Reinhold-Keller E, Beuge N, Latza U et al (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients Arthritis Rheum 43: 1021-1032
21. Reinhold-Keller E, De Groot K, Rudert H, Noelle B, Heller M, Gross WL (1996) Response to trimethoprim/sulfamethoxazole in Wegener's granulomatosis depends on the phase of disease QJM 89 15-23
22. Reinhold-Keller E, Fink C, Herlyn K, Gross WL, de Groot K (2002) High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate. Arthritis Care Res 47: 326-332
23. Reinhold-Keller E, Zeidler A, Gutfleisch J, Peter HH, Raspe HH, Gross WL (2000) Giant cell arteritis is more prevalent in urban than in rural populations results of an epidemiological study of primary systemic vasculitides in Germany Rheumatology (Oxford) 39: 1396-1402
24. Stegeman CA, Cohen Tervaert JA, Manson WL, Sluiter WJ, de Jong PE, Kallenberg CGM (1994) Chronic nasal carriage of Staphylococcus aureus in Wegener's granulomatosis identifies a subgroup of patients more prone to relapses Ann Intern Med 120: 12-17
25. Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Huffman GS (2001) Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety Arthritis Rheum 44: 1149-1154
26. Wegener F (1939) Uber eine eigenartige rhinogene Granulomatose mit besonderer Beteiligung des Arteriensystems und der Nieren Beitr Pathol Anatom 102 36-68